Innoscripta - Public Comps and Valuation Multiples

Innoscripta Overview

About Innoscripta

Innoscripta SE is a software company specializing in cloud-based compliance software for research and development. It provides R&D tax incentives consulting.

Founded

2012

HQ

Employees

n/a

Website

innoscripta.com

Sectors

Financial Management Software
FinTech
B2B SaaS
Horizontal SaaS

Financials

LTM Revenue $120M

LTM EBITDA $68.2M

EV

$971M

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Innoscripta Financials

As of December 2025, Innoscripta reported last 12-month revenue of $120M and EBITDA of $68.2M.

In the same period, Innoscripta generated $120M in LTM gross profit and $45.2M in net income.

See Innoscripta valuation multiples based on analyst estimates

Innoscripta P&L

In the most recent fiscal year, Innoscripta reported revenue of $75.6M and EBITDA of $44.0M.

Innoscripta expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Innoscripta valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2026	FY 2027	FY 2028
Revenue	$120M	XXX	$75.6M	XXX	XXX	XXX
Gross Profit	$120M	XXX	$56.1M	XXX	XXX	XXX
Gross Margin	100%	XXX	74%	XXX	XXX	XXX
EBITDA	$68.2M	XXX	$44.0M	XXX	XXX	XXX
EBITDA Margin	57%	XXX	58%	XXX	XXX	XXX
EBIT	$68.4M	XXX	$43.6M	XXX	XXX	XXX
EBIT Margin	57%	XXX	58%	XXX	XXX	XXX
Net Profit	$45.2M	XXX	$29.3M	XXX	XXX	XXX
Net Margin	38%	XXX	39%	XXX	XXX	XXX
Net Debt	XXX	XXX	n/a	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Innoscripta including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $120M. EBITDA for the last twelve months was $68.2M. In the most recent fiscal year, Innoscripta achieved $75.6M in revenue and $44.0M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2026)	Next Fiscal Year (2027)	Two Years Forward (2028)
Total Revenue	$120M	Analyst estimates available to subscribers	$75.6M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	$120M	Analyst estimates available to subscribers	$56.1M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	99.9% gross margin	Analyst estimates available to subscribers	74.2% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	$68.2M	Analyst estimates available to subscribers	$44.0M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	56.8% EBITDA margin	Analyst estimates available to subscribers	58.2% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	$68.4M	Analyst estimates available to subscribers	$43.6M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	57.0% EBIT margin	Analyst estimates available to subscribers	57.7% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	$45.2M	Analyst estimates available to subscribers	$29.3M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	37.7% net profit margin	Analyst estimates available to subscribers	38.8% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	n/a	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Innoscripta

This financial data table provides comprehensive performance metrics for Innoscripta, a company based in Germany. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

Innoscripta generated $120M in revenue over the last twelve months.
The company achieved $68.2M in EBITDA over the last twelve months.
Gross profit for the last twelve months was $120M.
Net income over the last twelve months reached $45.2M.

Fiscal Year Performance

In the most recent fiscal year, Innoscripta reported $75.6M in total revenue.
Fiscal year EBITDA was $44.0M.
The company maintained a gross profit margin of 74.2% in the most recent fiscal year.
EBITDA margin for the fiscal year was 58.2%.
Net profit margin reached 38.8% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Innoscripta. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Innoscripta Stock Performance

Innoscripta has current market cap of EUR 858M (or $1.0B), and EV of EUR 832M (or $971M).

Market Cap Evolution

Innoscripta Stock Data

As of January 16, 2026, Innoscripta's stock price is EUR 86 (or $100).

See Innoscripta trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$971M	$1.0B	XXX	XXX	XXX	XXX	$4.54

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Innoscripta Valuation Multiples

Innoscripta's trades at 8.1x EV/Revenue multiple, and 14.2x EV/EBITDA.

See valuation multiples for Innoscripta and 15K+ public comps

Innoscripta Financial Valuation Multiples

As of January 16, 2026, Innoscripta has market cap of $1.0B and EV of $971M.

Equity research analysts estimate Innoscripta's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Innoscripta has a P/E ratio of 22.1x.

	LTM	NTM	Last FY	FY 2026	FY 2027	FY 2028
Market cap (current)	$1.0B	XXX	$1.0B	XXX	XXX	XXX
EV (current)	$971M	XXX	$971M	XXX	XXX	XXX
EV/Revenue	8.1x	XXX	8.1x	XXX	XXX	XXX
EV/EBITDA	14.2x	XXX	14.2x	XXX	XXX	XXX
EV/EBIT	14.2x	XXX	14.2x	XXX	XXX	XXX
EV/Gross Profit	8.1x	XXX	n/a	XXX	XXX	XXX
P/E	22.1x	XXX	22.1x	XXX	XXX	XXX
EV/FCF	31.1x	XXX	31.1x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Innoscripta Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Innoscripta Margins & Growth Rates

Innoscripta's last 12 month revenue growth is 40%

Innoscripta's revenue per employee in the last FY averaged n/a, while opex per employee averaged n/a for the same period.

Innoscripta's rule of 40 is 79% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Innoscripta's rule of X is 156% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Innoscripta and other 15K+ public comps

Innoscripta Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2026	FY 2027	FY 2028
Revenue Growth	40%	XXX	35%	XXX	XXX	XXX
EBITDA Margin	57%	XXX	57%	XXX	XXX	XXX
EBITDA Growth	36%	XXX	93%	XXX	XXX	XXX
Rule of 40	79%	XXX	96%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	156%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	n/a	XXX	XXX	XXX
Opex per Employee	XXX	XXX	n/a	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	17%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial